Drugs for diabetes and endocrine disorders are among a list of 100 prescription medications that should be more affordable for patients after being added to the PBS 60-day continuous dispensing scheme from 1 March.
The 60-day prescription scheme means that patients can potentially get two scripts for the price of one. According to health minister Chris Butler, this means Australians without a concession card will save up to $189 per medicine, per year. Pensioners and concession cardholders will save up to $46.20 per medicine, per year.
Anti-diabetes medications added to the list include acarbose, alogliptin, dapagliflozin, empagliflozin, glibenclamide, glicazide, glimepiride, glipizide, linagliptin, metformin, pioglitazone, saxagliptin and sitagliptin.
Other endocrine medications now available on 60-day scripts include alendronate + colecalciferol, bromocriptine, cabergoline, cyproterone, propylthiouracil, quinagolide, tamoxifen and other anti-androgens.
The move was welcomed by Diabetes Australia which said that expanding 60-day dispensing would lighten the financial burden for people living with diabetes and also reduce the need for GP and pharmacy visits for prescriptions.
“Many people living with diabetes are taking two or three medicines to manage their condition, as well as additional medications to treat other issues such as blood pressure, heart disease, or mental health challenges,” the group said in a statement.
“As the cost of these medicines pile up, we often hear from people about how hard it can be to pay for all of these prescriptions, particularly as they struggle with cost-of-living pressures.”